Results 161 to 170 of about 206,504 (296)

Impact of cryoballoon size adjustability on procedural and clinical outcomes. [PDF]

Europace
Kikkoji N, Miyazaki S, Nitta J, Sasaki T, Yamauchi Y, Yamashita S, Sagawa Y, Shirai Y, Inaba O, Suzuki A, Mizukami A, Suzuki M, Inamura Y, Hayasaka K, Arai H, Isonaga Y, Goto K, Nakamura R, Takahashi A, Hachiya H, Iwai S, Sasano T.   +21 more
europepmc   +1 more source

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour

British Journal of Clinical Pharmacology, EarlyView.
Aims Trial run‐in phases are sometimes used to select adherent participants as a strategy to enrich trials, but the methods employed lack clear regulatory guidance and there are concerns about the transparency of reporting. This review aims to characterize the methods used for adherence measurement and public reporting of run‐in studies.
Non Davies, Bernard Vrijens, Daniel F. B. Wright, Dyfrig A. Hughes   +3 more
wiley   +1 more source

A soft policy instrument with a hard content? An analysis of national agreements in Swedish multi-level healthcare. [PDF]

J Health Organ Manag
Wide J, Feltenius D.
europepmc   +1 more source

Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims To evaluate the effects of vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) oestrogen receptor degrader, on the pharmacokinetics of dabigatran (a P‐glycoprotein [P‐gp] substrate) and rosuvastatin (a breast cancer resistance protein [BCRP] substrate).
Derek Z. Yang, Li Zhou, Jennifer A. Winton, Kyle T. Matschke, Constantino Kantaridis, Kristine Doyle, Kimberly C. Lee, Naihan Chen, Yuanyuan Zhang, Weiwei Tan   +9 more
wiley   +1 more source

A qualitative case study of body image in women with breast cancer participating in an exercise program. [PDF]

Support Care Cancer
Mateu P, Teixidor-Batlle C, Suárez-Alcázar MP, Salas-Medina P, Catalá-Vilaplana I, Hernando-Domingo C, Muriach M, Collado-Boira E.   +7 more
europepmc   +1 more source

Perceived managerial discretion and firm performance: The moderating role of market competition

, 2010
Xi-Ping Zhao, Po‐Young Chu, Chia-Yi Chen   +2 more
openalex   +1 more source

Navigating adverse immunostimulation: A practical guide for clinical researchers

British Journal of Clinical Pharmacology, EarlyView.
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort, Anouk C. Meijs, Naomi B. Klarenbeek, Matthijs Moerland   +3 more
wiley   +1 more source

The Microfoundations of Organizational Risk. [PDF]

Risk Anal
Soane E.
europepmc   +1 more source

The Impact of Ownership Structure and Other Corporate Governance Mechanisms on Firm Performance, Accounting Discretions and Investor Perceptions: Evidence from Thailand before and after the Corporate Governance Reforms

, 2013
Karuntarat Boonyawat
openalex   +1 more source

Agency Discretion and Public Health Service Delivery

, 2009
Pamela J. Clouser McCann
openalex   +2 more sources